Vitamin d and cardiovascular disease: An appraisal of the evidence

Clinical Chemistry

Volumn 60, Issue 4, 2014, Pages 600-609

  Schnatz, Peter F ^a,b,c,d   Manson, Joann E ^e  

^a Departments of Obstetrics and Gynecology   (United States)

^b READING HOSPITAL AND MEDICAL CENTER   (United States)

^c Depts of Obstetrics and Gynecology   (United States)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; COLECALCIFEROL; LIPID;

BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIETARY REFERENCE INTAKE; DISEASE ASSOCIATION; GLUCOSE TOLERANCE; HOMEOSTASIS; HUMAN; ISCHEMIC HEART DISEASE; LABORATORY TEST; LIPID BLOOD LEVEL; META ANALYSIS (TOPIC); NUTRITIONAL REQUIREMENT; OBSERVATIONAL STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

25-HYDROXYVITAMIN D 2; CORONARY ARTERY DISEASE; DIETARY SUPPLEMENTS; HOMEOSTASIS; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS;

EID: 84897516098     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2013.211037     Document Type: Review

References (79)

1. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, et al. AHA statistical update: heart disease and stroke statistics-2011 update; a report from the American Heart Association. Circulation 2011;123:e18 -209.
2. Mosca L, Barrett-Connor E, Kass Wenger N. Sex/ gender differences in cardiovascular disease prevention: what a difference a decade makes. Circulation 2011;124:2145-54.
3. Lloyd-Jones DM, Larson MG, Beiser A, Levey D. Lifetime risk of developing coronary heart disease. Lancet 1999;353:89-92. (Pubitemid 29088076)
4. Mosca L, Banka CL, Benjamin EJ, Berra K, Bezanson JL, Dolor RJ, et al. Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation 2007;115: 1481-501. (Pubitemid 46648385)
5. Mosca L, Grundy SM, Judelson D, King K, Limacher M, Oparil S, et al. AHA/ACC scientific statement: consensus panel statement. Guide to preventative cardiology for women. American Heart Association/American College of Cardiology. J Am Coll Cardiol 1999;33:1751-5.
6. Kones R. Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey. Drug Des Devel Ther 2011;5:325-80.
7. Grimes DS, Hindle E, Dyer T. Sunlight, cholesterol and coronary heart disease. Q J Med 1996;89: 579-89. (Pubitemid 26278869)
8. Rostand SG. Ultraviolet light may contribute to geographic and racial blood pressure differences. Hypertension 1997;30:150-6. (Pubitemid 27328990)
9. Giovannucci E, Liu Y, Hollis BW, Rimm EB. 25- Hydroxyvitamin D and risk of myocardial infarction in men. Arch Intern Med 2008;168:1174-80. (Pubitemid 351831400)
10. Forman JP, Giovannucci E, Homes MD, Bischoff- Ferrari HA, Tworoger SS, Willett WC, Curhan GC. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 2007;49: 1063-9. (Pubitemid 351664326)
11. Pilz S, Marz W, Wellnitz B, Seelhorst U, Fahrleitner-Pammer A, Dimai HP, et al. Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. J Clin Endocrinol Metab 2008;93:3927-35.
12. Melamed ML, Munter P, Michos ED, Uribarri J, Weber C, Sharma J, Raggi P. Serum 25- hydroxyvitamin D levels and the prevalence of peripheral arterial disease. Atheroscler Thromb Vasc Biol 2008;28:1179-85.
13. Targher G, Bertolini L, Padvoani R, Targher G, Bertolini L, Padovani R, et al. Serum 25- hydroxyvitamin D3 concentrations and carotid artery intima-media thickness among type 2 diabetic patients. Clin Endocrinol 2006;65:593-7. (Pubitemid 44583818)
14. Tsai KS, Wahner HW, Offord KP, Melton LJ, Kumar R, Riggs BL. Effect of aging vitamin D stores and bone density in women. Calcif Tissue Int 1987;40:241-3. (Pubitemid 19014735)
15. Henry HL, Norman AW. Studies on calciferol metabolism. IX. Renal 25-hydroxy-vitamin D3-1 hydroxylase. Involvement of cytochrome P-450 and other properties. J Biol Chem 1974;249:7529-35.
16. Holick MF. Vitamin D deficiency. N Engl J Med 2007;357:266-81.
17. Bouillon R, Carmeliet G, Verlinden L, Van Etten E, Verstuyf A, Luderer HF, et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 2008;29:726-76.
18. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008;117:503-11.
19. Manson JE, Bassuk SS. Vitamin D and cardiovascular disease. Menopause Manag 2009;18:28-31.
20. Zella LA, Shevde NK, Hollis BW, Cooke NE, Pike JW. Vitamin D-binding protein influences total circulating levels of 1,25-dihydroxyvitamin D3 but does not directly modulate the bioactive levels of the hormone in vivo. Endocrinology 2008;149: 3656-67. (Pubitemid 351919607)
21. Paula B, Ghetu MV, Langan R. Recognition and management of vitamin D deficiency. Am Fam Physician 2009;80:841-6.
22. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000;72:690-3. (Pubitemid 30667088)
23. Scragg R. Seasonality of cardiovascular disease mortality and the possible protective effect of ultraviolet radiation. Int J Epidemiol 1981;10: 337-41. (Pubitemid 12164635)
24. Tangpricha V, Pearce EN, Chen TC, Holick MF. Vitamin D insufficiency among free-living healthy young adults. Am J Med 2002;112:659-62. (Pubitemid 34597167)
25. Merke J, Milde P, Lewicka S, Hugel U, Klaus G, Mangelsdorf DJ, et al. Identification and regulation of 1,25-dihydroxyvitamin D3 receptor activity and biosynthesis of 1,25-dihydroxyvitamin D3. Studies in cultured bovine aortic endothelial cells and human dermal capillaries. J Clin Invest 1989; 83:1903-15. (Pubitemid 19148859)
26. Schnatz PF, Nudy M, O'Sullivan DM, Jiang X, Cline JM, Kaplan JR, et al. The quantification of vitamin D receptors in coronary arteries and their association with atherosclerosis. Maturitas 2012; 73:143-7.
27. Schnatz PF, Nudy M, O'Sullivan DM, Jiang X, Cline JM, Kaplan JR, et al. Coronary artery vitamin D receptor expression and plasma concentrations of vitamin D: their association with atherosclerosis. Menopause 2012;19:967-73.
28. Wu-Wong JR, Nakane M, Ma J, Ruan X, Kroeger PE. Effects of vitamin D analogs on gene expression profiling in human coronary artery smooth muscle cells. Atherosclerosis 2006;186:20-8.
29. Rostkowska-Nadolska B, Sliupkas-Dyrda E, Potyka J, Kusmierz D, Fraczek M, Krecicki T, et al. Vitamin D derivatives: calcitriol and tacalcitol inhibits interleukin-6 and interleukin-8 expression in human nasal polyp fibroblast cultures. Adv Med Sci 2010;55:86-92.
30. Schnatz PF, Vila-Wright S, Jiang X, Register TC, Kaplan JR, Clarkson TB, Appt SE. The association between plasma 25OHD3 concentrations, C-reactive protein levels, and coronary artery atherosclerosis in postmenopausal monkeys. Menopause 2012;19:1074-80.
31. Cantorna MT, Hayes CE, DeLuca HF. 1,25- Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis. J Nutr 1998;128:68-72. (Pubitemid 28087178)
32. Li YC, Qiao G, Uskokovic M, Xiang W, Zheng W, Kong J. Vitamin D: A negative endocrine regulator of the renin-angiotensin system and blood pressure. J Steroid Biochem Mol Biol 2004;89:387-92. (Pubitemid 38844316)
33. Gedik O, Akalin S. Effects of vitamin D deficiency and repletion on insulin and glucagon secretion in man. Diabetologia 1986;29:142-5. (Pubitemid 16137021)
34. Muscogiuri G, Sorice GP, Ajjan R, Mezza T, Pilz S, Prioletta A, et al. Can vitamin D deficiency cause diabetes and cardiovascular diseases? Present evidence and future perspectives. Nutr Metab Cardiovasc Dis 2012;22:81-7.
35. Schnatz PF, Nudy M, O'Sullivan DM, Ethun K, Appt SE, Clarkson TB. Identification of a mechanism for increased cardiovascular risk among individuals with low vitamin D concentrations. Menopause 2011;18:994-1000.
36. Merlino LA, Curtis J, Mikuls TR, Cerhan JR, Criswell LA. Vitamin D: intake is inversely associated with rheumatoid arthritis. Arthritis Rheum 2004;50:72-7.
37. Zipitis CS, Akobeng AK. Vitamin D supplementation in early childhood and risk of type 1 diabetes: A systematic review and meta-analysis. Arch Dis Child 2008;93:512-7. (Pubitemid 352025770)
38. Pittas AG, Dawson-Hughes B, Li T, Van Dam RM, Willett WC, Manson JE, et al. Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 2006;29:650-6. (Pubitemid 44115368)
39. Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006;296: 2832-8. (Pubitemid 44969183)
40. Wang L, Song Y, Manson JE, Pilz S, März W, Michaëlsson K, et al. Circulating 25-hydroxyvitamin D and risk of cardiovascular disease: A meta-analysis of prospective studies. Circ Cardiovasc Qual Outcomes 2012;5:819-29.
41. MacLaughlin J, Holick MF. Aging decreases the capacity of human skin to produce vitamin D3. J Clin Invest 1985;76:1536-8. (Pubitemid 16193572)
42. Reid D, Toole BJ, Knox S, Talwar D, Harten J, O'Reilly DJS, et al. The relation between acute changes in the systemic inflammatory response and plasma 25-hydroxyvitamin D concentrations after elective knee arthroplasty. Am J Clin Nutr 2011;93:1006-11.
43. Chung M, Balk EM, Brendel M, Ip S, Lau J, Lee J, et al. Vitamin D and calcium: A systematic review of health outcomes. Evidence report no. 183 (prepared by the Tufts Evidence-based Practice Center under contract no. HHSA 290-2007-10055-I). AHRQ publication no. 09-E015. Rockville, MD: Agency for Healthcare Research and Quality; 2009.
44. IOM. Dietary reference intakes for calcium and vitamin D. Ross AC, Taylor CL, Yaktine AL, Del Valle HB, eds. Washington (DC): National Academies Press; 2011. http://books.nap.edu/ openbook.php?record-id-13050&page-R1 (Accessed February 2014).
45. IOM. Dietary reference intakes for calcium and vitamin D [Report Brief]. 2010 Nov. http://www.iom.edu/~/media/Files/Report%20Files/2010/Dietary- Reference-Intakes-for-Calcium-and-Vitamin-D/ Vitamin%20D%20and%20Calcium%202010%20Report%20Brief.pdf (Accessed February 2014).
46. Trivedi DP, Doll R, Khaw KT. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 2003;326:469-75.
47. De Boer IH, Tinker LF, Connelly S, Curb JD, Howard BV, Kestenbaum B, et al. Calcium plus vitamin D supplementation and the risk of incident diabetes in the Women's Health Initiative. Diabetes Care 2008;31:701-7.
48. Ponda MP, Dowd K, Finkielstein D, Holt PR, Breslow JL. The short-term effects of vitamin D repletion on cholesterol: A randomized, placebocontrolled trial. Arterioscler Thromb Vasc Biol 2012;32:2510-5.
49. Margolis KL, Ray RM, Van Horn L, Manson JE, Allison MA, Black HR, et al., for the Women's Health Initiative Investigators. Effect of calcium and vitamin D supplementation on blood pressure: the Women's Health Initiative Randomized Trial. Hypertension 2008;52:847-55.
50. Hsai J, Heiss G, Ren H, Allison M, Dolan NC, Greenland P, et al. Calcium/vitamin D supplementation and cardiovascular events. Circulation 2007;115:846-54. (Pubitemid 46294725)
51. Gepner AD, Ramamurthy R, Krueger DC, Korcarz CE, Binkley N, Stein JH. A prospective randomized controlled trial of the effects of vitamin D supplementation on cardiovascular disease risk. PLoS One 2012;7:e36617.
52. Witham MD, Dove FJ, Dryburgh M, Sugden JA, Morris AD, Struthers AD. The effect of vitamin D replacement on markers of vascular health in stroke patients - a randomised controlled trial. Nutr Metab Cardiovasc Dis 2012;22:864-70.
53. Manson JE, Allison MA, Carr JJ, Langer RD, Cochrane BB, Hendrix SL, et al. Calcium/vitamin D supplementation and coronary artery calcification in the Women's Health Initiative. Menopause 2010;17:683-91.
54. Jorde R, Figenschau Y. Supplementation with cholecalciferol does not improve glycaemic control in diabetic subjects with normal serum 25- hydroxyvitamin D levels. Eur J Nutr 2009;48:349-54.
55. Zittermann A, Frisch S, Berthold HK, Götting C, Kuhn J, Kleesiek K, et al. Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr 2009 89:1321-7.
56. Schleithoff SS, Zittermann A, Tenderich G, Berthold HK, Stehle P, Koerfer R. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: A doubleblind, randomized, placebo-controlled trial. Am J Clin Nutr 2006;83:754-9. (Pubitemid 44713136)
57. Jorde R, Sneve M, Torjesen P, Figenschau Y. No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitamin D3 for 1 year. J Intern Med 2010;267:462-72.
58. Inkovaara J, Gothoni G, Halttula R, Heikinheimo R, Tokola O. Calcium, vitamin D and anabolic steroid in treatment of aged bones: double-blind placebo-controlled long-term clinical trial. Age Ageing 1983;12:124-30. (Pubitemid 15212123)
59. Prentice RL, Pettinger MB, Jackson RD, Wactawski-Wende J, LaCroix AZ, Anderson GL, et al. Health risks and benefits from calcium and vitamin D supplementation: Women's Health Initiative clinical trial and cohort study. Osteoporos Int 2013;24:567-80.
60. Forman JP, Scott JB, Ng K, Drake BF, Suarez EG, Hayden DL, et al. Effect of vitamin D supplementation on blood pressure in blacks. Hypertension 2013;61:779-85.
61. Autier P, Gandini S. Vitamin D supplementation and total mortality. Arch Intern Med 2007;167: 1730-7.
62. Rejnmark L, Avenell A, Masud T, Anderson F, Meyer HE, Sanders KM, et al. Vitamin D with calcium reduces mortality: patient level pooled analysis of 70,528 patients from eight major vitamin D trials. J Clin Endocrinol Metab 2012;97:2670-81.
63. Elamin MB, Abu Elnour NO, Elamin KB, Fatourechi MM, Alkatib AA, Almandoz JP, et al. Vitamin D and cardiovascular outcomes: A systematic review and meta-analysis. J Clin Endocrinol Metab 2011;96:1931- 42.
64. Vimaleswaran KS, Berry DJ, Lu C, Tikkanen E, Pilz S, Hiraki LT, et al. Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med 2013;10:e1001383.
65. International Osteoporosis Foundation (IOF). IOF position statement: vitamin D recommendations for older adults - position paper. http://www.natap.org/2010/HIV/072310-01.htm (Accessed October 2013).
66. National Osteoporosis Foundation. Calcium and vitamin D: what you need to know. . nof.org/aboutosteoporosis/prevention/vitamind (Accessed October 2013).
67. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011;96:1911-30.
68. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 2011;96: 53-8.
69. National Institute of Standards and Technology (NIST). http://www.nist.gov/index.html (Accessed August 2013).
70. Sempos CT, Vesper HW, Phinney KW, Thienpont LM, Coates PM. Vitamin D status as an international issue: national surveys and the problem of standardization. Scand J Clin Lab Invest Suppl 2012;243:32-40.
71. Graham DC. Accuracy of 25-hydroxyvitamin D assays: confronting the issues. Curr Drug Targets 2011;12:19-28.
72. Lewis JG, Elder PA. Serum 25-OH vitamin D2 and D3 are stable under exaggerated conditions. Clin Chem 2008;54:1931-2.
73. Manson JE, Bassuk SS, Li I, Cook NR, Albert MA, Gordon D, et al. The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized control trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. Contemp Clin Trials 2012;33:159-71.
74. Pilz S, Rutters F, Dekker JM. Disease prevention: vitamin D trials. Science 2012;338:883.
75. Ginde AA, Liu MC, Camargo CA. Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med 2009;169:626-32.
76. Hunter D, De Lange M, Snieder H, MacGregor AJ, Swaminathan R, Thakker RV, Spector TD. Genetic contribution to bone metabolism, calcium excretion, and vitamin D and parathyroid hormone regulation. J Bone Miner Res 2001;16:371-8. (Pubitemid 32105418)
77. Karohl C, Su S, Kumari M, Tangpricha V, Veledar E, Vaccarino V, Raggi P. Heritability and seasonal variability of vitamin D concentrations in male twins. Am J Clin Nutr 2010;92:1393-8.
78. Wang TJ, Zhang F, Richards JB, Kestenbaum B, van Meurs JB, Berry D, et al. Common genetic determinants of vitamin D insufficiency: A genome-wide association study. Lancet 2010; 376:180-8.
79. Gutiérrez OM, Farwell WR, Kermah D, Taylor EN. Racial differences in the relationship between vitamin D, bone mineral density, and parathyroid hormone in the National Health and Nutrition Examination Survey. Osteoporos Int 2011;22: 1745-53.